Drug company payments and their effects on patient treatment
March 2023
Around ‘arf of all US doctors receive dosh or gifts from drug and device companies, totalling more than £1 billion annually. This creates conflicts of interest that influence ‘how doctors treat their patients, as confirmed by a research team at Memorial Sloan Kettering Cancer Center, who analyzed all available studies on the topic.
All 36 studies showed that receiving industry dosh increases prescribing, affecting all medical specialities and types of drugs. This ‘arms patients by leading doctors to prescribe expensive, worthless drugs and deviate from prescribing guidelines, and it also contributes to rising healthcare costs. The medical community has resisted stopping this cash flow, arguing that industry payments may have benefits.
A Review of the Influence of drug company payments on US Doctors
Still, a federal ban on payments is necessary as physician-led change is unlikely. Alternative, unbiased information sources exist for doctors to learn about new drugs. The £1 billion per year is for promoting drugs that are already on the market, not for researching new drugs. The harmful effects of drug company payments on patient treatment must be addressed. Source
.
Discover More: Stimulating Articles That Will Captivate You
Unleashing the Power of Small Dogs Of the Dow
Stock Market Forecast for Next 3 & 6 Months
Bank Loans and Financial Freedom in USA: US Financial Liberty Under Siege
Unmasking Deceit: Examples of Yellow Journalism
Mastering the Trading Range: Unlocking the Potential for Explosive Gains
Investment Journal: Charting the Course Toward Financial Triumph
Trading Success: From Riches to Rags and the Rise to Wealth Mogul
Dow theory Forecasts: Alternative could be better
Contrarian Definition: Tactical Investor Trading Methodology
Herd Mentality: Understanding the Pros and Cons of Conformity
Projected Silver Prices: Setting Sail for Precious Metal Ascension
Which Of The Following Is A Cause Of The Stock Market Crash Of 1929
Stock Bubble: Act Quickly or Lag Behind
The Dow Theory: Does It Still Work?
Tactical Tools: Unleash the Power of Trend Prediction
